reSee.it - Related Video Feed

Not many people in Canada have immunity to the infection, which shows that they have done a great job in preventing its spread. This lack of immunity is due to the low number of natural infections.

It is disturbing to see other groups becoming involved with AIDS as the months go by, including children. Close contact can lead to AIDS. For example, if a child's close contact is a household contact, there will be cases of individuals living in close contact with someone with AIDS or at risk of AIDS. This contact does not necessarily have to be intimate sexual contact or sharing a needle, but just ordinary close contact.

The speaker states that a disease, surmised early on, began in the male homosexual population in the U.S. The speaker clarifies that this was not due to anything intrinsically wrong with homosexuality, but rather straightforward epidemiology. Introducing an infectious agent into a population where sexual contact is the mode of transmission creates a perfect setup for spread. The speaker notes a concentration of cases in the New York Metropolitan Area (New York City and New Jersey) and in Los Angeles.

This disease initially affected the male homosexual population in the US. The spread was facilitated by sexual contact. The concentration of cases was observed in the New York metropolitan area, including New York City and New Jersey, as well as in Las Vegas.

COVID spreads quickly in crowds, especially as winter approaches and people spend more time indoors with less ventilation. Seeing friends, colleagues, and family also increases the risk of transmission.

The speaker discusses the eradicability of viruses, focusing on the case of AIDS. They mention four criteria for eradicability: the absence of an animal reservoir, the virus not persisting in infected humans for years, the absence of multiple serological types, and the ability to obtain the necessary social cooperation. The speaker argues that AIDS violates all four criteria, suggesting that it will remain a long-term problem along with related viruses.

Children are now being affected by AIDS, which is concerning. Close contacts like household members are at risk, even without intimate or needle-sharing contact. This shows that AIDS can spread through everyday interactions, not just through specific activities.

The speaker discusses how the disease initially spread among the male homosexual population in the United States. They clarify that this does not imply anything negative about homosexuality, but rather it is a result of straightforward epidemiology. The concentration of cases was observed in the New York Metropolitan Area, including New York City and New Jersey, as well as in Los Angeles. The speaker emphasizes the importance of introducing an infectious agent into a population for it to spread.

This Catholic run home, the Incarnation Children's Center in Harlem, is where many HIV children end up if their parents or guardians refuse to medicate them. For years, it was the center of highly controversial and secretive drug trials on orphans and foster children as young as three months old. At the time, these assertions describe a setting and activities that have sparked significant scrutiny, with emphasis on secrecy surrounding the research and the vulnerability of the children involved. The transcript presents these points without concluding on the ethics or outcomes. Further context or details are not included in this excerpt.

AIDS, initially seen as a disease affecting only gay individuals, is a condition that weakens the immune system and can lead to Kaposi's sarcoma, a rare form of cancer. This cancer has a high death rate of 80% within two years of diagnosis. AIDS also causes severe infections with a 100% death rate within two years. It is not a benign disease and is not limited to the gay community. Currently, 75% of cases are among homosexuals, 14% among heterosexual drug addicts, 5% among heterosexuals with no other risk factors, 5% among Haitian refugees, and 1% among hemophiliacs who likely contracted it through blood transfusions. Females who are partners of male drug addicts and infants of female drug addicts can also be affected.

The disease initially affected the male homosexual population in the US, particularly in New York City, New Jersey, and Los Angeles. Introducing an infectious agent into this population through sexual contact facilitated its spread.

Many homeless men are sick and untested, some are dangerous. It's hard to trust anyone here.

The concerning issue is that the virus can infect multiple species, including pigs, which are often in close proximity to chickens and cows. This interaction raises the risk of a reassortment of viruses, potentially creating a new strain that combines the dangerous traits of H5N1 with the ability to spread between humans. Public health officials are particularly worried about this possibility due to the mixing of viruses in pigs. Although the current risk is considered low, the CDC emphasizes the need for vigilance as the situation could change.

The early belief was that AIDS was limited to the male homosexual community and IV drug users. However, it was later discovered that groups like Haitians and hemophiliacs were also affected, and there were concerns about transmission through blood transfusions. A recent article by Alasky revealed that children in close contact with individuals at high risk for AIDS showed symptoms identical to AIDS syndrome, suggesting that the disease could be transmitted through intimate contact rather than just sexual or blood transmission. This led to speculation in the media that AIDS could be spread through casual contact, causing unnecessary fear.

There is a dangerous and deadly disease called AIDS that poses a threat to everyone. It can be transmitted through sexual intercourse with an infected person, affecting both men and women. Although it has mainly affected small groups, it is spreading. It is crucial to protect yourself by being aware and informed. Ignoring AIDS could lead to death, so it is important not to die due to ignorance. This message was conveyed in a public information film.

AZT is the only drug available because it's the only one proven safe and effective in scientific trials. While progress may seem slow, many drugs are in clinical trials. These trials aim to determine their safety and effectiveness. Drugs in trial include Alpha interferon, dideoxycytidine, phos carnate, and al seven twenty one, either alone or with AZT. The virus is spreading heterosexually, but not as explosively as in the homosexual population years ago. Complacency should be avoided. In the US, heterosexual spread is concentrated among IV drug abusers and their partners, particularly in areas like Manhattan, South Bronx, New Jersey, and Miami. Regarding one scientist's claims, they are considered extraordinary and off base. He puts forth a negative hypothesis without offering alternatives, creating anxiety among infected individuals who may perceive a conspiracy.

Children's immune systems are being compromised by toxic agents, preventing them from developing natural immunity. The younger they are when exposed, the greater the risk of long-term complications, including an increased risk of cancer. There are alarming reports of sudden deaths in children, including heart attacks in two-year-olds, which were previously unheard of. Cases of strokes in young children are also rising, with some attributing this to genetic predispositions. However, these incidents are now occurring in otherwise healthy young individuals, raising concerns about the implications of recent medical interventions.

The speaker states that vaccines contained 40 different viruses that were being inactivated. The yellow fever vaccine contained leukemia virus due to the crude science of the time. The speaker says they were not reporting AIDS virus at the time, but they had a disease virus. The speaker says it was good science at the time because they didn't worry about these viruses.

When an infectious disease outbreak occurs, aggressive actions can change its expected shape.

The documentary traces the global HIV/AIDS story through shifting science, politics, testing, treatment, and personal narratives, revealing a landscape of debate, fear, and influence that has shaped how the epidemic is understood and managed. From the outset, the film juxtaposes dramatic claims about the virus with questions about complacency, fear, and the human cost of AIDS. Early voices warn that HIV remains a deadly virus despite reduced fear, while others emphasize a persistent problem for individuals and the vast number of people living with the virus. The central tension is set: can a cure be found, and what would it take? A through-line is the distinction between HIV and AIDS. The narrator and interviewees seek clarity on what causes AIDS, how HIV relates to it, and why the distinction matters for diagnosis and treatment. Experts emphasize core definitions: HIV is a virus; AIDS is a syndrome caused by infection with the virus; you don’t get infected with AIDS, you get infected with HIV which can lead to AIDS. Yet the dialogue also documents persistent public confusion about the difference, and shows that international definitions and country-specific criteria have evolved and sometimes diverged, complicating diagnosis and statistics. The film surveys the history of HIV/AIDS terminology and surveillance. It highlights the GRID term, the early CDC framework, and the 1985, 1987, and 1993 definition changes that broadened AIDS criteria, sometimes to include people with varying CD4 counts or opportunistic infections. A retroactive redefinition in 1993 reportedly increased estimates, and a Bangui criteria conference in Africa sought a simple clinical way to diagnose AIDS in settings with limited lab access. World Health Organization definitions multiply across countries, leading to several AIDS definitions worldwide and debates about how to interpret the numbers. The program documents how testing has driven both diagnosis and fear, including debates over screening versus confirmatory testing. It shows rapid antibody tests, ELISAs, Western blots, and viral-load tests, noting limitations and discrepancies: rapid tests may yield false positives or negatives, confirmatory tests can yield inconsistent results across manufacturers, and in some settings, developing nations rely on screening tests without adequate confirmatory verification. The story includes personal accounts of misdiagnosis, false positives, and the emotional toll of testing, as well as examples where people faced life-altering decisions based on uncertain results. The film also questions the reliability of testing narratives in light of varied international criteria and the economics of testing. The narrative shifts to Africa, particularly South Africa, where the epidemic intersects with poverty, infrastructure, and policy debates. It documents the perception that Africa bears the highest incidence of AIDS, the Bangui criteria’s adoption in Africa, the social and economic context, and the role of poverty as a deadly factor that can mimic or exacerbate immune deficiency. It also notes skepticism about how data are compiled and presented, including claims that numbers are influenced by advocacy, funding incentives, and political considerations. The film chronicles the evolution of treatment from AZT monotherapy to highly active antiretroviral therapy (HAART) and the cocktail era, detailing dramatic shifts in prognosis and the emergence of drug toxicity and side effects. Personal testimonies recount adverse reactions, weight changes, lipodystrophy, heart risks, and the existential dilemma of lifelong treatment versus quality of life. The dramatic arc notes that, while HAART transformed AIDS from a fatal disease to a manageable chronic condition for many, the treatment introduced new side effects and ethical concerns about prescribing practices, access, and the long-term effects of therapy. A recurring theme is the tension between scientific consensus and dissenting voices. The film presents prominent figures associated with HIV research and advocacy, including discussions of the role of Robert Gallo, Françoise Barré-Sinoussi, and Montagnier, and the geopolitical dynamics around the virus’s identification and acceptance as the cause of AIDS. It includes accounts of cofactor theories proposing that other factors—cofactors beyond HIV—may influence progression and that poverty, malnutrition, and coexisting infections can affect immune function. Some interviewees critique the dominance of a single narrative and suggest that alternative explanations have been marginalized or labeled as unscientific. Personal stories punctuate the analysis: families learning of HIV status, the experience of testing in settings from a South African train station to clinics in Romania, and the emotional and practical consequences of a positive diagnosis. The film documents the journey from diagnosis to treatment, including the trials and revelations of those who have acquired, faced, or combated the disease, and those who question or reconsider the standard medical narrative. Towards the end, the documentary reflects on the broader social and ethical implications: the cost and allocation of billions in AIDS funding, the disproportionate burden on poorer nations, the role of activism and politics in shaping policy, and the ongoing uncertainty about optimal testing, diagnosis, and cure. It closes by acknowledging the resilience of people living with HIV and those who work to understand and treat the virus, while underscoring that many fundamental questions about HIV, AIDS, and their interconnections remain debated in scientific and public spheres. The conclusion suggests that the epidemic’s true battles may extend beyond biology to include poverty, access, governance, and the politics of data.

The disease initially spread in the male homosexual population in the US, mainly in New York City, New Jersey, and Los Angeles. The infectious agent was introduced through sexual contact, leading to a concentration of cases in these areas.

There are allegations that AIDS was intentionally spread in African countries through vaccines. Research facilities were set up to inject people with a solution to prevent AIDS, but instead, they were injecting people with AIDS. These facilities were financed by foreign governments. Additionally, there have been cases where HIV vaccines actually increased the likelihood of infection, showing that a vaccine that seemed safe initially could have negative effects.

AIDS can be transmitted before an individual develops infections and is classified as having AIDS. The spread of the disease is facilitated by sexual contact. It's important to note that there are many individuals who already have the defect but are not classified as having AIDS. The statistics on AIDS only consider full-blown cases and do not account for the large number of individuals with the defect. The transmissibility of the disease is another crucial aspect to consider.

Speaker 0: A child born in a hospital in The United States today, within an hours of coming from source into this body, the first thing that happens to them is pharmaceutical intervention without really asking, barely informed consent. That child's eyes are smeared with erythromycin ointment, and they're given a hepatitis B vaccine in their first day of life. And the hep B vaccine is for hepatitis B, which is a sexually transmitted disease, an IV drug user disease, of course, which babies are not gonna be exposed to, and yet every single baby in America is getting the intervention. So from the literally the day we are born, we're— Speaker 1: I these mean, why not test the pregnant mother for those? Speaker 0: They do. Speaker 1: Okay. Speaker 0: So They give it to the women who even if they have tested negative— Speaker 1: they give majority. Absolutely. So I don't understand why would you treat a child on his first day of life for illnesses you know for a fact he doesn't have, it isn't gonna get? Speaker 2: So a child's born let's just take the sign. The child's born. Hep B is spread by two routes, sexually transmitted disease or intravenous needles. So my one day old isn't going to be having sex or doing heroin right away. So what's the purpose of getting this on the schedule in the first day of life, the first hours of life? Speaker 0: And if you push, and I welcome anyone to do this with their doctor, you get to two things. You get to the American patients are too stupid to remember, so we need to do it right away. That's literally like what they say. And then my doctor told me that that a child at daycare could trip over a needle that has hepatitis B on it. That's literally what they get to. Speaker 2: That a needle could be on the playground that somebody just did heroin or something, threw the needle down, and it has hepatitis B blood on it. I asked the doctor, has there ever been in human history a case of hepatitis B two being transferred that way? They said no. It's only through intravenous needles and sex. So you actually to to just to steel man this, and, again, welcome anyone to respond, there is not actually a scenario absent of intravenous needles or sex, that a person gets hepatitis b. Speaker 0: There is not a reason for this to be given.

Children and women are using harmful substances that are disgusting and need to be stopped.